U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499570) titled 'Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD' on Mar... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499869) titled 'INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR' on March 24. Brief Summary: Temporomandibu... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501806) titled 'Effect of the Combination of Nitrate and Caffeine on Critical Power In Trained Male Cyclis... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501429) titled 'Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury' on March 23. ... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501546) titled 'Enhancing Childhood Obesity Interventions Through Digital Media Tools' on March 24. Brief... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501455) titled 'Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Micr... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07502196) titled 'Heart Problems in Children With Chronic Liver Disease' on March 25. Brief Summary: Chroni... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07499128) titled 'Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Rel... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500467) titled 'Upadacitinib for Refractory Takayasu Arteritis' on March 24. Brief Summary: Takayasu arte... Read More
U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500298) titled 'Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treat... Read More